GAMMA Investing’s Verona Pharma VRNA Stock Holding History

GAMMA Investing’s Portfolio VRNA Stock Details VRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-1,935	Closed	-$206K	–	4148
2025 Q3	$206K	Sell	1,935 -5	-0.3%	-$522	0.01%	961
2025 Q2	$183K	Buy	1,940 +103	+6%	+$7.63K	0.01%	967
2025 Q1	$117K	Buy	1,837 +225	+14%	+$13.5K	0.01%	1134
2024 Q4	$74.9K	Buy	1,612 +276	+21%	+$10.4K	0.01%	1332
2024 Q3	$38.4K	Buy	1,336 +553	+71%	+$13.6K	﹤0.01%	1681
2024 Q2	$11.3K	Buy	783 +417	+114%	+$6.09K	﹤0.01%	2183
2024 Q1	$5.89K	Buy	366 +349	+2,053%	+$6.04K	﹤0.01%	2335
2023 Q4	$312	Buy	+17	New	+$251	﹤0.01%	3043

Other funds holding VRNA

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

GAMMA Investing's VRNA Position: Q4 2025 in Review

GAMMA Investing sold out of Verona Pharma (VRNA) in Q4 2025, closing a stake of 1,935 shares — an estimated $206K sold.

GAMMA Investing first reported a position in VRNA in Q4 2023 and held it in 8 quarters. The position peaked at $206K in Q3 2025. 1 fund tracked by Wall St. Rank holds VRNA as of Q4 2025.

GAMMA Investing reported no remaining Verona Pharma position as of Q4 2025 after selling out during the quarter.
GAMMA Investing sold 1,935 Verona Pharma shares in Q4 2025, an estimated $206K.
GAMMA Investing first reported a position in Verona Pharma in Q4 2023 and held it in 8 quarters.
GAMMA Investing's Verona Pharma position peaked at $206K in Q3 2025.
1 fund tracked by Wall St. Rank held Verona Pharma as of Q4 2025.

Based on GAMMA Investing's 13F filing for Q4 2025, filed 5 Jan 2026.